ADVERTISEMENT
See Inside December 2004

Antidepressants: Good Drugs or Good Marketing?

A scandal over hidden data about adolescent suicide lights a dark corner of our drug approval system

This article was originally published with the title "Perspectives: Antidepressants: Good Drugs or Good Marketing."

(Further Reading)

  • Suppression of Mosholder’s findings and testimony is documented by Anna Wilde Mathews’s article “In Debate over Antidepressants, FDA Weighed Risk of False Alarm Doubting Data on Suicide and Kids” in Wall Street Journal; May 25, 2004. Viewable at www.ahrp.org/infomail/04/05/25.html
  • Drug Company Experts Advised Staff to Withhold Data about SSRI Use in Children. Wayne Kondro in Canadian Medical Association Journal, Vol. 170; No. 5; March 2, 2004. Available online at www.cmaj.ca/cgi/content/full/170/5/783
Share this Article:

Comments

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Scientific American Back To School

Back to School Sale!

12 Digital Issues + 4 Years of Archive Access just $19.99

Order Now >

X

Email this Article

X